Medications and support to help hospitalized heart and lung patients quit smoking
Official title: Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease
Funded at Baystate Medical Center, INC. · NIH-11314529 · Data updated 2026-11-12
This project uses tailored quit-smoking medicines, nurse counseling, and supportive text messages to help hospitalized adults with heart or lung disease stop smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baystate Medical Center, INC. NIH-funded |
| Lab location | 1 site (Springfield, United States) |
| Project start | March 15, 2022 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $644,639 |
| NIH project number | 5R01HL156851-05 |
| Project ID | NIH-11314529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Hospitalized adult smokers with heart or lung disease who are willing to try prescription smoking-cessation medications and receive counseling and text-message support.
✕Less likely to help
People who do not smoke, who are not hospitalized at a participating site, who cannot receive or use mobile phone text messages, or who have medical reasons they cannot take cessation medications may not benefit from this program.
What this research studies
If you are hospitalized with a heart or lung condition, a nurse practitioner-led tobacco treatment team would prescribe guideline-recommended quit-smoking medicines matched to your needs. The team would counsel and coach you in the hospital so you know how to use the medicines and stay motivated. After discharge you would get automated text messages to support adherence and reduce the chance of relapse. The program aims to close the gap between guideline recommendations and what patients actually receive in hospitals.
Why it matters
Potential benefit: If successful, this could help more hospitalized smokers with cardiopulmonary disease quit and reduce smoking-related complications after discharge.
How similar studies have gone: Combining medicines, counseling, and text-message support has improved quit rates in other studies, and the team's preliminary data show this hospital-based, NP-led approach is feasible.
Where this research is happening
-
Baystate Medical Center, INC.
Springfield, United States Active
Researchers
- Principal investigator: Pack, Quinn Russell — Baystate Medical Center, INC.
- Study coordinator: Pack, Quinn Russell
Related research
Other NIH-funded projects on the same topics.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
-
Smoking cessation help for people with HIV in South Africa
A program is being tested to help people living with HIV in South Africa quit smoking in ways that fit low-resource clinics and show good value.
-
Mobile tools to understand how sleep affects quitting smoking
This project uses a smartphone to track sleep and smoking in lower-income adults trying to quit to find how sleep patterns relate to staying smoke-free.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Peer-led smoking-cessation program for public housing residents
A peer-led program with eight group sessions plus nicotine replacement therapy is tested on adults living in public housing to help them quit smoking.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.